In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States.

Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.

The first of three faculty town hall meetings to update and engage Vanderbilt’s faculty on the four foundational areas driving the strategic planning process is scheduled for Feb. 27.